Carla J. Greenbaum

Also affiliated with Washington Research Foundation

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 29 papers. Top paper: “Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes”.

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

Nature Genetics(2021)10.1038/s41588-021-00880-5

N/A

6.1DataRank · unranked

300 citations

Jamie Inshaw, Suna Önengüt-Gümüşcü, Wei‐Min Chen, David Flores Santa Cruz, Hanzhi Yang +26 more

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

JCI Insight(2021)10.1172/jci.insight.150074

N/A

2.2DataRank · unranked

59 citations

Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord +31 more

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

Diabetes Care(2024)10.2337/dci24-0042

N/A

1.6DataRank · unranked

70 citations

Peter Achenbach, Ananta Addala, Anastasia Albanese-O’Neill, Tadej Battelino, Kirstine J. Bell +61 more

Heterogeneity in recent‐onset type 1 diabetes – a clinical trial perspective

Diabetes/Metabolism Research and Reviews(2015)10.1002/dmrr.2643

N/A

1.4DataRank · unranked

26 citations

Ping Xu, Atul Janardhan Butte, Darrell M. Wilson, Craig A. Beam, Carla J. Greenbaum +3 more

Impaired β-Cell Function, Incretin Effect, and Glucagon Suppression in Patients With Type 1 Diabetes Who Have Normal Fasting Glucose

Diabetes(2002)10.2337/diabetes.51.4.951

N/A

0.713DataRank · unranked

115 citations

Ronald L. Prigeon, David A. D’Alessio, Carla J. Greenbaum

Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

Diabetes Care(2023)10.2337/dc22-2200

N/A

0.691DataRank · unranked

99 citations

Brian N. Bundy, Mark S. Anderson, Laura A. Cooney, Stephen E. Gitelman, Robin Goland +21 more

Hydroxychloroquine in Stage 1 Type 1 Diabetes

Diabetes Care(2023)10.2337/dc23-1096

N/A

0.622DataRank · unranked

17 citations

Polly J. Bingley, Dorothy J. Becker, Jane H. Buckner, Linda A. DiMeglio, Stephen E. Gitelman +58 more

C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis

The Lancet Diabetes & Endocrinology(2023)10.1016/s2213-8587(23)00267-x

N/A

0.612DataRank · unranked

58 citations

Kimberly S. Collins, Anna Lam, Stephen R. Karpen, Brianna Greeno, Frank Walker +38 more

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Science Translational Medicine(2021)10.1126/scitranslmed.abc8980

N/A

0DataRank · unranked

361 citations

Brian N. Bundy, Kenneth Stier, Elisavet Serti, Noha Lim, S. Alice Long +18 more

Insulin is necessary but not sufficient: changing the therapeutic paradigm in type 1 diabetes

F1000Research(2020)10.12688/f1000research.21801.1

N/A

0DataRank · unranked

13 citations

Carla J. Greenbaum, Sandra Lord

Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01

Diabetes(2020)10.2337/db19-0620

N/A

0DataRank · unranked

47 citations

Perrin Guyer, Thomas Delong, Mylinh Dang, I‐Ting Chow, Cate Speake +6 more

Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes

JCI Insight(2021)10.1172/jci.insight.151349

N/A

0DataRank · unranked

34 citations

Fariba Barahmand-pour-Whitman, Elisa Balmas, Hannah A. DeBerg, Kaitlin J. Flynn, Alex Hu +14 more

Citrullination of glucokinase linked to autoimmune diabetes

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.28.441829

N/A

0DataRank · unranked

0 citations

Sheryl Horstman, Renelle J. Gee, Perrin Guyer, TuKiet T. Lam, Jean Kanyo +9 more

Permutational immune analysis reveals architectural similarities between inflammaging, Down syndrome and autoimmunity

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.13.460115

N/A

0DataRank · unranked

0 citations

Keagan G. Moo, Azlann Arnett, Gautam Goel, Kaitlin J. Flynn, Cate Speake +7 more

Citrullination of glucokinase is linked to autoimmune diabetes

Nature Communications(2022)10.1038/s41467-022-29512-0

N/A

0DataRank · unranked

35 citations

Sheryl Horstman, Renelle J. Gee, Perrin Guyer, TuKiet T. Lam, Jean Kanyo +10 more

IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function

JCI Insight(2022)10.1172/jci.insight.159436

N/A

0DataRank · unranked

21 citations

Tania Habib, Katharina Lambert, Christian Hundhausen, Sandra Lord, Matthew J. Dufort +11 more

Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes Diagnosis

The Journal of Clinical Endocrinology & Metabolism(2022)10.1210/clinem/dgac594

N/A

0DataRank · unranked

10 citations

Alyssa Ylescupidez, Henry T. Bahnson, Christine Bender, Cate Speake, Sandra Lord +2 more

IL-6-Driven pSTAT1 Response Is Linked to T Cell Features Implicated in Early Immune Dysregulation

Frontiers in Immunology(2022)10.3389/fimmu.2022.935394

N/A

0DataRank · unranked

8 citations

Kirsten E. Diggins, Britta E. Jones, Christian Hundhausen, Megan D. Maerz, Anne M. Hocking +6 more

A Standardized Metric to Enhance Clinical Trial Design and Outcome Interpretation in Type 1 Diabetes

medRxiv(2022)10.1101/2022.12.21.22283684

N/A

0DataRank · unranked

0 citations

Henry T. Bahnson, Colin O’Rourke, Sandra Lord, Cate Speake, Carla J. Greenbaum +1 more

Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

The Lancet Diabetes & Endocrinology(2023)10.1016/s2213-8587(23)00082-7

N/A

0DataRank · unranked

61 citations

Élodie Drumez, Cassandra Ballou, Mehdi Maanaoui, Elizabeth H. Payne, Franca B. Barton +68 more

OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody–Positive Individuals

The Journal of Clinical Endocrinology & Metabolism(2023)10.1210/clinem/dgad472

N/A

0DataRank · unranked

38 citations

Cate Speake, Susan L. Pietropaolo, Darrell M. Wilson, Andrea K. Steck, Jennifer L. Sherr +5 more

Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes

JCI Insight(2023)10.1172/jci.insight.167881

N/A

0DataRank · unranked

27 citations

Janice Chen, Alex Hu, Hannah A. DeBerg, Mario G. Rosasco, Vivian H. Gersuk +7 more

A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes

Nature Communications(2023)10.1038/s41467-023-42581-z

N/A

0DataRank · unranked

22 citations

Henry T. Bahnson, Colin O’Rourke, Sandra Lord, Cate Speake, Carla J. Greenbaum +1 more

Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes

Diabetologia(2020)10.1007/s00125-020-05179-4

N/A

0DataRank · unranked

42 citations

Matthew J. Dufort, Alba Llibre, Cate Speake, M. Jubayer Rahman, Vincent Bondet +6 more

Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae292

N/A

0DataRank · unranked

9 citations

Colin O’Rourke, Alyssa Ylescupidez, Megan E. Smithmyer, Christine Bender, Cate Speake +3 more

The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa348

N/A

0DataRank · unranked

7 citations

Mario A. Cleves, Jay M. Sosenko, Ingrid Libman, David A. Baidal, Ashok Balasubramanyam +80 more

Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR

PLoS ONE(2020)10.1371/journal.pone.0242049

N/A

0DataRank · unranked

47 citations

David Gebhart, Peter V. Robinson, David Seftel, Narges Pourmandi, Jordan Owyoung +15 more

Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood

UNC Libraries(2020)10.17615/fscj-1a60

N/A

0DataRank · unranked

0 citations

Paul Wadwa, Beth A. Reboussin, James Amrhein, Barbara Linder, J Neff +64 more

The influence of exposure to maternal diabetes in utero on the rate of decline in β-cell function among youth with diabetes

UNC Libraries(2020)10.17615/9f37-cy93

N/A

0DataRank · unranked

0 citations

David J. Pettitt, Ralph B. D’Agostino, Tessa Crume, Elizabeth J. Mayer‐Davis, Dana Dabelea +7 more